Induction Of Labor: Predictors of Outcomes (IOL-ID)

April 14, 2020 updated by: Sherif Abdelkarim Mohammed Shazly, Assiut University

Outcomes of Induction of Labor: a Prospective Multi-center Study

Induction of labor is a widely used intervention in OBGYN practice. Doctors still use the old Bishop score in patients' follow up. It remains difficult to anticipate the outcomes and the possibility of adverse effects during this process. In this large prospective multicentric interventional study, we aim to develop a more precise and sensitive score based on machine learning tools programmed on python 3.8

This new tool will account for many variables in patient demography(age, race, weight ... etc ) and medical history (previous OBGYN surgery, comorbidities .... etc). These variables not usually found in the classic bishop score. We predict that our analysis will aid doctors in making better decisions and efficiently predict the outcomes, need for switching to operative delivery and possible complications.

Machine learning and digital calculation of hazards will allow more precise assessment and more efficient management during IOL as it considers variables not included in clinical scores.

this study aims to provide modern and efficient assessment parameters to guide clinical decision making during the IOL process and help doctors predict its outcomes based on subtle factors not usually considered.

This will minimize the complications and allow more evidence-based practice.

Study Overview

Status

Unknown

Intervention / Treatment

Detailed Description

the objective is to create a database registry documenting the induction of labor (IOL) process and apply machine learning tools to create a more precise assessment score for doctors as a contemporary follow-up method.

we will collect data from at least 12 centers worldwide describing the course, outcomes, maternal or fetal complications, and any related data. The data will be collected after ethical approval and from consenting patients in a prospective manner. during the period from July 1st, 2020 to June 30th, 2021 (anticipated dates).

each center will be responsible for quality assessment, data collection, and ensuring the data is accurate, complete, and representative.

Data collection includes baseline pelvic examination (cervical position, consistency, dilation, effacement, fetal position, and bishop score), method of induction and their time of administration in relation to index time (start of IOL), findings and time of serial pelvic examinations, fetal heart tone, and maternal vital signs. The entry of data from serial examinations will continue during active labor and fetal and maternal outcomes will be reported. If the diagnosis of failed IOL is made and obstetric team decides delivery by Cesarean section, criteria of diagnosis/indication of Cesarean delivery will be reported. Length of active labor and the second stage will be documented, and maternal/perinatal complications will be reported. the collectors must ensure patient confidentiality and safety.

Inclusion criteria:-

  • Pregnant women admitted for IOL, aged between 18 to 40 years
  • Term or late preterm pregnancy (gestational age at 34 weeks or beyond)
  • A reassuring fetal heart tracing prior to IOL

Exclusion criteria:-

  • Fetal growth restriction with abnormal Doppler indices
  • Intrauterine fetal death
  • Suspected intra-amniotic infection prior to IOL
  • Fetal major congenital anomalies
  • Patients who decline IOL in prior or during IOL without medical indication

statistical analysis :- Data will be described using (mean, median, standard deviation, range) in the final sample. Machine learning method is superior to traditional statistical methods as it provides robust and automatic estimation of complex relationships between different variables and clinical outcomes. Data will be utilized as xi and yi where xi presents input (features) and yi presents dependent variables (outcomes). Functional regression is based on support vector machine by regressing the outcomes yi on inputs xi. Model Validation will be performed via bootstrap estimation to evaluate the predictive ability of the functional regression models. Data will be split to training data (approximately 63% of the data) to create prediction model where bootstrapping will be applied, and testing data where prediction model will be validated. Machine learning models will be created using python 3.8.

Study Type

Interventional

Enrollment (Anticipated)

3000

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 40 years (Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

Female

Description

Inclusion Criteria:

  • Pregnant women admitted for IOL, aged between 18 to 40 years
  • Term or late preterm pregnancy (gestational age at 34 weeks or beyond)
  • Reassuring fetal heart tracing prior to IOL

Exclusion Criteria:

  • Fetal growth restriction with abnormal Doppler indices
  • Intrauterine fetal death
  • Suspected intra-amniotic infection prior to IOL
  • Fetal major congenital anomalies
  • Patients who decline IOL in priori or during IOL without medical indication

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Diagnostic
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Other: induction of labor monitoring
meticulous data collection from patients and plotting that data in a machine learning model
Giving drugs to facilitate uterine contractions and fasten the process of delivery
Other Names:
  • non operative vaginal delivery

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Cesarean section rate
Time Frame: Within 24 hours from start of induction of labor
Incidence and indication of Cesarean section following induction of labor
Within 24 hours from start of induction of labor

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Suspected intraamniotic infection
Time Frame: From start of induction of labor to 24 hours after delivery
Maternal pyrexia > 39 or > 38 on 2 occasions
From start of induction of labor to 24 hours after delivery
Postpartum hemorrhage
Time Frame: From start of induction of labor to 24 hours after delivery
Blood loss > 1000 ml after delivery
From start of induction of labor to 24 hours after delivery
Low neonatal APGAR Score
Time Frame: 5 minutes after delivery
APGAR score < 7 at 5 minutes postpartum
5 minutes after delivery
Admission to neonatal intensive care unit
Time Frame: Within 1 hour of delivery
Admission of the newborn to intensive care unit and its indication
Within 1 hour of delivery

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Sherif Shazly, M.S, Assiut University

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Anticipated)

July 1, 2020

Primary Completion (Anticipated)

June 30, 2021

Study Completion (Anticipated)

July 30, 2021

Study Registration Dates

First Submitted

April 11, 2020

First Submitted That Met QC Criteria

April 14, 2020

First Posted (Actual)

April 17, 2020

Study Record Updates

Last Update Posted (Actual)

April 17, 2020

Last Update Submitted That Met QC Criteria

April 14, 2020

Last Verified

April 1, 2020

More Information

Terms related to this study

Other Study ID Numbers

  • IOL-ID

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Induction of Labor Affected Fetus / Newborn

Clinical Trials on induction of labor

Subscribe